In another randomized controlled trial with NAFLD patients, black cumin treatment (1 g twice a day for three months) caused a decline in BMI, ALT, AST, and overall fatty liver grading on ultrasound following 12 weeks of treatment compared to the placebo group (Hosseini et al., 2018). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.